Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (Nasdaq: FRBN) is a blank-check company sponsored by Forbion Capital Partners, a Netherlands-based venture capital firm specializing in life sciences and healthcare. The SPAC completed its initial public offering in 2021 and targeted acquisition opportunities in the European life sciences sector, including biotechnology, medical devices, and related healthcare industries. The company filed an amended quarterly report on Form 10-Q/A with the SEC on March 10, 2023, under accession number 0001193125-23-066332, reflecting ongoing reporting obligations during its search for a suitable business combination target. Sign up at SpacDesk for full filing history, deal timelines, and sponsor analytics on FRBN and hundreds of other SPACs.